At a Glance
- Dr. Lucia Gaitan becomes first Miami provider for Cerene cryotherapy.
- Procedure targets heavy menstrual bleeding using cooling technology.
- Clinical data shows 90% patient satisfaction rates after one year.
Lucia Gaitan, M.D., FACOG, a board-certified obstetrician and gynecologist, has become the first medical professional in Miami to provide Cerene Endometrial Cryotherapy. This medical procedure offers a new option for women suffering from heavy menstrual bleeding, also known as menorrhagia. By utilizing cooling technology rather than heat, the treatment aims to reduce menstrual flow while maintaining a high safety profile. The introduction of this technology marks a shift in how local outpatient facilities manage common gynecological conditions through advanced medical devices.
Clinical Efficacy and Patient Outcomes
The Cerene procedure utilizes cryotherapy to treat the uterine lining, which significantly reduces the volume of menstrual discharge. Data from clinical trials indicates that 90% of patients experienced normal, light, or no periods one year after the treatment. This high success rate suggests that the cooling method is an effective alternative to traditional surgical interventions or hormonal therapies.
Heavy menstrual bleeding affects millions of women annually, often leading to anemia and significant physical discomfort. Many patients seek treatments that do not require daily medication or the permanency of a hysterectomy. This cryotherapy option fills a gap for those looking for a middle ground that preserves the uterus while resolving symptoms.
In addition to reducing blood flow, the treatment addresses secondary symptoms associated with heavy periods. Specifically, 86% of patients reported a notable reduction in menstrual cramping following the procedure. These findings highlight the potential for improved quality of life for women who previously struggled with debilitating monthly symptoms and missed work days.
The procedure is designed for an office setting, allowing patients to avoid the complexities of hospital-based surgery. Most individuals return to their normal daily activities within 24 hours. This rapid recovery period makes it a viable option for working professionals and those with active lifestyles who cannot afford lengthy downtime.
"I am pleased to be the first in Miami to offer Cerene Endometrial Cryotherapy to my patients. This procedure is a significant advancement in the treatment of heavy menstrual bleeding, providing a safe and effective option that can be performed in the office with minimal downtime."
— Lucia Gaitan, M.D., FACOG at Lucia Gaitan, M.D.
Technological Advancements in Cryotherapy
Unlike traditional endometrial ablation techniques that use heat, Cerene employs extreme cold to deactivate the lining of the uterus. This cooling effect provides a natural numbing sensation, which often reduces the need for general anesthesia or heavy sedation. Consequently, Lucia Gaitan, M.D. can perform the treatment using only local numbing agents in a clinical setting.
The device is FDA-cleared and specifically engineered to protect the surrounding uterine tissue during the process. This precision ensures that the treatment is localized and minimizes the risk of thermal injury to adjacent organs. The safety features integrated into the device provide physicians with greater control during the three-minute application period.
Channel Medsystems developed this technology to address the limitations of earlier ablation methods. By focusing on cryotherapy, the company created a device that integrates safety sensors and automated controls. This ensures that the cooling process remains consistent across different patient anatomies and uterine shapes.
Physicians have noted that the lack of heat-based scarring may offer advantages in post-procedure monitoring. Traditional methods can sometimes lead to uterine adhesions that complicate future diagnostic evaluations. The cryotherapy approach maintains the integrity of the uterine cavity, which is a significant consideration for long-term gynecological health and monitoring.
The adoption of Cerene cryotherapy in the Miami market reflects a growing trend toward minimally invasive office-based procedures. As more patients seek alternatives to hysterectomy or long-term medication, technology-driven solutions like cryotherapy are expected to see increased utilization. Dr. Gaitan’s introduction of this service provides local residents with expanded access to modern gynecological care. Future clinical evaluations will likely continue to monitor the long-term durability of these results within the South Florida patient population.